Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial
argenx
Catherine M Broome; Vickie McDonald; Yoshitaka Miyakawa; Monica Carpenedo; David J Kuter; Hanny Al-Samkari; James B Bussel; Marie Godar; Jaume Ayguasanosa; Kristof De Beuf; Francesco Rodeghiero; Marc Michel; Adrian Newland; ADVANCE Investigator Study Group